Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $13,610 | 8 | 60.7% |
| Consulting Fee | $5,154 | 5 | 23.0% |
| Food and Beverage | $3,539 | 36 | 15.8% |
| Travel and Lodging | $128.35 | 3 | 0.6% |
| Education | $5.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $14,270 | 17 | $0 (2022) |
| Mallinckrodt Enterprises LLC | $3,997 | 12 | $0 (2019) |
| CALLIDITAS THERAPEUTICS US INC. | $2,376 | 6 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $462.04 | 4 | $0 (2017) |
| PFIZER INC. | $385.78 | 2 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $215.00 | 2 | $0 (2019) |
| Veloxis Pharmaceuticals, Inc. | $196.98 | 3 | $0 (2019) |
| One Lambda, Inc. | $146.39 | 1 | $0 (2024) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $124.37 | 2 | $0 (2018) |
| ANI Pharmaceuticals, Inc. | $120.69 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,345 | 4 | CALLIDITAS THERAPEUTICS US INC. ($2,198) |
| 2023 | $325.46 | 4 | Calliditas Therapeutics US Inc. ($155.03) |
| 2022 | $1,986 | 6 | Horizon Therapeutics plc ($1,964) |
| 2021 | $5,329 | 5 | Horizon Therapeutics plc ($5,329) |
| 2020 | $4,840 | 7 | Horizon Therapeutics plc ($4,817) |
| 2019 | $2,524 | 5 | Horizon Therapeutics plc ($2,160) |
| 2018 | $994.01 | 9 | Mallinckrodt LLC ($483.86) |
| 2017 | $4,092 | 13 | Mallinckrodt LLC ($3,389) |
All Payment Transactions
53 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/21/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: Nephrology | ||||||
| 10/01/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $142.85 | General |
| Category: Nephrology | ||||||
| 03/20/2024 | One Lambda, Inc. | — | Food and Beverage | Cash or cash equivalent | $146.39 | General |
| 01/18/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $55.60 | General |
| Category: Nephrology | ||||||
| 08/17/2023 | Calliditas Therapeutics US Inc. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $106.58 | General |
| Category: Nephrology | ||||||
| 07/11/2023 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $120.69 | General |
| Category: Treatment of certain chronic autoimmune disorders, including acute exacerbations of MS and RA | ||||||
| 05/19/2023 | Calliditas Therapeutics US Inc. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $48.45 | General |
| Category: Nephrology | ||||||
| 05/04/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $49.74 | General |
| Category: Rare Disease | ||||||
| 08/19/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $108.36 | General |
| Category: KRYSTEXXA | ||||||
| 08/10/2022 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: Nephrology | ||||||
| 06/06/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: KRYSTEXXA | ||||||
| 06/05/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Honoraria | Cash or cash equivalent | $1,620.00 | General |
| Category: KRYSTEXXA | ||||||
| 06/05/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $138.09 | General |
| Category: KRYSTEXXA | ||||||
| 06/05/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Consulting Fee | In-kind items and services | $74.80 | General |
| Category: KRYSTEXXA | ||||||
| 09/10/2021 | Horizon Therapeutics plc | PROCYSBI (Drug) | Honoraria | Cash or cash equivalent | $2,250.00 | General |
| Category: PROCYSBI | ||||||
| 08/12/2021 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $126.05 | General |
| Category: KRYSTEXXA | ||||||
| 06/17/2021 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Honoraria | Cash or cash equivalent | $1,620.00 | General |
| Category: KRYSTEXXA | ||||||
| 06/17/2021 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Consulting Fee | In-kind items and services | $73.00 | General |
| Category: KRYSTEXXA | ||||||
| 02/25/2021 | Horizon Therapeutics plc | PROCYSBI (Drug) | Honoraria | Cash or cash equivalent | $1,260.00 | General |
| Category: PROCYSBI | ||||||
| 12/11/2020 | Horizon Therapeutics plc | PROCYSBI (Drug) | Honoraria | Cash or cash equivalent | $1,080.00 | General |
| Category: PROCYSBI | ||||||
| 06/24/2020 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: IMMUNOLOGY | ||||||
| 06/16/2020 | Horizon Therapeutics plc | PROCYSBI (Drug) | Honoraria | Cash or cash equivalent | $1,260.00 | General |
| Category: PROCYSBI | ||||||
| 02/21/2020 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $32.99 | General |
| Category: KRYSTEXXA | ||||||
| 02/21/2020 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $32.00 | General |
| Category: KRYSTEXXA | ||||||
| 02/17/2020 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Honoraria | Cash or cash equivalent | $2,360.00 | General |
| Category: KRYSTEXXA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 676 | 1,184 | $315,989 | $112,117 |
| 2022 | 10 | 598 | 1,196 | $311,022 | $108,237 |
| 2021 | 12 | 845 | 1,404 | $331,509 | $115,131 |
| 2020 | 14 | 829 | 1,414 | $350,021 | $103,025 |
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 197 | 345 | $110,400 | $39,068 | 35.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 174 | 404 | $70,700 | $26,739 | 37.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 100 | 214 | $54,142 | $21,686 | 40.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 84 | 95 | $31,920 | $10,439 | 32.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 59 | 63 | $31,248 | $9,192 | 29.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 12 | 12 | $5,580 | $1,706 | 30.6% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 23 | 23 | $5,405 | $1,276 | 23.6% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 16 | 17 | $4,284 | $1,191 | 27.8% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2023 | 11 | 11 | $2,310 | $820.50 | 35.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 190 | 339 | $108,480 | $40,488 | 37.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 131 | 431 | $75,425 | $25,575 | 33.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 83 | 206 | $52,118 | $17,923 | 34.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 47 | 54 | $26,784 | $9,160 | 34.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 59 | 64 | $21,504 | $7,437 | 34.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2022 | 30 | 37 | $7,770 | $2,128 | 27.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 16 | 16 | $7,440 | $1,823 | 24.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 13 | 18 | $3,978 | $1,428 | 35.9% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 12 | 14 | $3,528 | $1,225 | 34.7% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 17 | 17 | $3,995 | $1,048 | 26.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 198 | 562 | $98,350 | $33,559 | 34.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 152 | 175 | $56,000 | $21,937 | 39.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 182 | 241 | $53,261 | $18,365 | 34.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 67 | 144 | $36,432 | $12,735 | 35.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 79 | 84 | $28,224 | $9,684 | 34.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 45 | 49 | $24,304 | $8,385 | 34.5% |
About Dr. Vasil Peev, M.D
Dr. Vasil Peev, M.D is a Nephrology healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/21/2008. The National Provider Identifier (NPI) number assigned to this provider is 1427229087.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vasil Peev, M.D has received a total of $22,436 in payments from pharmaceutical and medical device companies, with $2,345 received in 2024. These payments were reported across 53 transactions from 13 companies. The most common payment nature is "Honoraria" ($13,610).
As a Medicare-enrolled provider, Peev has provided services to 2,948 Medicare beneficiaries, totaling 5,198 services with total Medicare billing of $438,510. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Chicago, IL
- Active Since 03/21/2008
- Last Updated 02/20/2015
- Taxonomy Code 207RN0300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1427229087
Products in Payments
- PROCYSBI (Drug) $8,010
- KRYSTEXXA (Biological) $6,260
- ACTHAR (Biological) $4,020
- TARPEYO (Drug) $2,376
- SOLIRIS (Drug) $462.04
- ENTRESTO (Drug) $215.00
- Envarsus XR (Drug) $140.98
- PURIFIED CORTROPHIN GEL (Drug) $120.69
- Rayaldee (Drug) $69.47
- Envarsus (Drug) $56.00
- ANDEXXA (Biological) $49.74
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Chicago
Nicole Stankus
Nephrology — Payments: $241,812
Susan Quaggin, Md, MD
Nephrology — Payments: $235,919
Lorenzo Gallon, Md, MD
Nephrology — Payments: $187,956
John Friedewald, Md, MD
Nephrology — Payments: $131,619
Arlene Chapman
Nephrology — Payments: $125,467
Dr. Jay Koyner, M.d, M.D
Nephrology — Payments: $87,521